Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
12/2007
12/21/2007WO2007144834A1 Sensitive magnetic assay through amplification of a label signal
12/21/2007WO2007144797A1 Integrated biosensing device having photo detector
12/21/2007WO2007144685A1 Cd4 mimic peptides and their uses
12/21/2007WO2007144671A1 Glazing inspection
12/21/2007WO2007144606A2 Mass spectrometry biomarker assay
12/21/2007WO2007144601A2 Lipoprotein assay
12/21/2007WO2007144491A2 Mobile unit for the treatment of raw water
12/21/2007WO2007144467A1 Diagnostic method for myopathy
12/21/2007WO2007144442A1 P53 fusion proteins without transcription activity, and applications thereof
12/21/2007WO2007144386A1 Method for taking and evaluating image sequences
12/21/2007WO2007144380A1 Detection of illicit administration of growth hormone
12/21/2007WO2007144367A1 Optical sensor and method for indicating the age or quality of a natural product
12/21/2007WO2007144356A1 Thermo-responsive blends and uses thereof
12/21/2007WO2007144194A1 In vitro multiparameter determination method for the diagnosis and early diagnosis of neurodegenerative disorders
12/21/2007WO2007144144A1 In vitro method for diagnosing and monitoring metastasized bladder cancer using the determination of mmp -7 in the circulation of patients
12/21/2007WO2007144077A2 Improved photostable fret-competent biarsenical-tetracysteine probes based on fluorinated fluoresceins
12/21/2007WO2007144001A2 Embryo quality assessment based on blastomere division and movement
12/21/2007WO2007143917A1 T cell epitope peptides of 6b11 ovarian cancer anti-idiotypic antibody
12/21/2007WO2007143819A1 Nitrogen limitation adaptibility gene and protein and modulation thereof
12/21/2007WO2007127977A3 Methods of evaluating peptide mixtures
12/21/2007WO2007124068A3 Method for analyzing foods
12/21/2007WO2007123830A3 Improvement of microcytoxicity assay by pre-labeling target cells
12/21/2007WO2007121721A3 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
12/21/2007WO2007116336A3 Method and apparatus for monitoring alteration of flow characteristics in a liquid sample
12/21/2007WO2007112876A3 Method and device for the analysis of isotope ratios
12/21/2007WO2007112350A3 Method of assessing the metastatic status of a primary tumor
12/21/2007WO2007109155A3 Assays for detection of antibodies to lysosomal enzymes
12/21/2007WO2007106810A3 Nmr method of detecting precipitants in a hydrocarbon stream
12/21/2007WO2007101979A3 Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system
12/21/2007WO2007101795A3 Method and device for testing the quality of a metallic coating
12/21/2007WO2007095378A3 Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate
12/21/2007WO2007095230A3 TREATMENT OF AUTOIMMUNE BLISTERING DISEASE USING ANTI-IgE ANTIBODY
12/21/2007WO2007090058A3 Lateral flow immunoassay with encapsulated detection modality
12/21/2007WO2007084734A3 Method to determine and biomarker for treatment efficacy with ssri, snri, and sari antidepressants
12/21/2007WO2007084486A3 Animal model for assessing copd-related diseases
12/21/2007WO2007071699A3 Methods for screening therapeutic efficacy of compositions in treatment of bone disease
12/21/2007WO2007055737A3 Biological detection system and method
12/21/2007WO2007047041A3 Methods and compositions for biomarkers associated with change in physical performance
12/21/2007WO2007042746A3 Ion source preparation system
12/21/2007WO2007041268A3 Transporter-targeted methods of diagnosis and treatment
12/21/2007WO2007035766A3 Biomarker for prostate cancer
12/21/2007WO2007035368A3 Methods of screening for immuno-adjuvants and vaccines comprising anti-microtubule immuno-adjuvants
12/21/2007WO2007033118A3 Mek interacting protein 1 and breast cancer
12/21/2007WO2006116296A3 Supplement to balance animal diets and method for supplement creation
12/21/2007WO2006088771A9 Apparatus and methods for analyzing body fluid samples
12/21/2007WO2006065613A3 Methods for identifying t cell activation-modulating compounds
12/21/2007WO2006044378A3 Rapid computational identification of targets
12/21/2007WO2005029040A3 System and methods for enhancing signal-to-noise ratios of microarray-based measurements
12/21/2007WO2004090106A3 Crystal structures of human pim-1 kinase protein complexes and binding pockets thereof, and uses thereof in drug design
12/21/2007WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy
12/21/2007WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007CA2836760A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007CA2690709A1 Glyceroglycolipid antigen of mycoplasma pneumoniae
12/21/2007CA2659720A1 Disease model incorporation into an artificial immune system (ais)
12/21/2007CA2659676A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007CA2659097A1 Novel methods for ester detoxication
12/21/2007CA2659082A1 Markers associated with arteriovascular events and methods of use thereof
12/21/2007CA2658331A1 Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
12/21/2007CA2657948A1 Denatured collagen peptides and uses thereof
12/21/2007CA2655563A1 Methods for detecting molecular complexes
12/21/2007CA2655471A1 Method for detecting il-16 activity and modulation of il-16 activity based on rantes proxy levels
12/21/2007CA2655420A1 Albumin-bound protein/peptide complex as a biomarker for disease
12/21/2007CA2655407A1 High water cut well measurements using heuristic salinity determination
12/21/2007CA2655405A1 Co-culture lymphoid tissue equivalent (lte) for an artificial immune system (ais)
12/21/2007CA2655371A1 Methods for regulating complement cascade proteins using astrovirus coat protein and derivatives thereof
12/21/2007CA2655362A1 Compositions and methods for diagnosing and treating cancer
12/21/2007CA2655010A1 Lipoprotein assay
12/21/2007CA2654980A1 Patches, systems, and methods for non-invasive glucose measurement
12/21/2007CA2654701A1 Cholesterol-regulating complex of sirt1 and lxr and methods of use
12/21/2007CA2652681A1 Sample pad system for controlling fluid movement between a sample receiving pad and a test strip
12/21/2007CA2651962A1 Anthrax compositions and methods of use and production
12/21/2007CA2651934A1 Mass spectrometry biomarker assay
12/21/2007CA2651846A1 Use of p11 to diagnose a p11/5-ht related disorder
12/21/2007CA2650127A1 Nitrogen limitation adaptibility gene and protein and modulation thereof
12/20/2007US20070294102 System and Method of Creating, Aggregating, and Transferring Environmental Emission Reductions
12/20/2007US20070294067 Prediction of estrogen receptor status of breast tumors using binary prediction tree modeling
12/20/2007US20070294037 System and Method for Optimizing Data Acquisition of Plasma Using a Feedback Control Module
12/20/2007US20070293659 Immobilization of glycoproteins
12/20/2007US20070293579 Use of carp inhibitors for the treatment of heart diseases
12/20/2007US20070293556 Prophylactic or Therapeutic Agent for Diabetic Maculopathy
12/20/2007US20070293535 Nuclear Transfer Promoter for Ddc42 Protein and Method of Screening the Dame
12/20/2007US20070293451 Regulation ao ApoB by Hsp110 proteins and related compositions and methods
12/20/2007US20070293450 Identification of ses-3 and the uses of same
12/20/2007US20070293437 Expression Profiling Platform Technology
12/20/2007US20070292972 Biomolecule Immobilisation Using Atmospheric Plasma Technology
12/20/2007US20070292971 Method of determining potential susceptibility to development of ALTE and/or SIDS
12/20/2007US20070292970 Method for Distinguishing Aml-Specific Flt3 Length Mutations From Tkd Mutations
12/20/2007US20070292969 Pregnancy test device
12/20/2007US20070292968 Adding boronic acid-derivative chiral receptor to indicator such as of alizarin red S, adding analyte such as alpha -hydroxyacid or amino acid, inspection of color with the naked eye, spectrographic measurement, or mathematical calculation
12/20/2007US20070292967 Assay for Ligands of the Ecdysone Receptor
12/20/2007US20070292966 Assessment of Skeletal Growth Using Measurements of Nt-Cnp Peptides
12/20/2007US20070292961 clearly visualizing a protein on a gel even when gel electrophoresis is performed using a small amount of the protein; use of sodium thiosulfate, sodium acetate and ethanolic silver nitrate
12/20/2007US20070292960 Relevance of achieved levels of markers of systemic inflammation following treatment
12/20/2007US20070292959 Sample Age Monitoring Devices And Methods
12/20/2007US20070292957 Sensor for Measuring Gas Permeability of a Test Material
12/20/2007US20070292956 Sensing Element for a Biosensor
12/20/2007US20070292955 Analytical Device And Method For Analysing A Sample, As Well As Injection Assembly For Use With Such An Analytical Device
12/20/2007US20070292944 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors
12/20/2007US20070292942 Light Scattering Determination of Treatment Potencies
12/20/2007US20070292934 Compositions and methods for detection of a target nucleic acid sequence
1 ... 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 ... 3937